Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05770388Not ApplicableCompleted

App-based Intervention to Promote Mental Health Help-seeking Among University Students

Role: collaborator

NCT04830527Not ApplicableTerminated

EMA Baseline Screening System for Therapists Who Treat Youths With Depressive Symptoms

Role: collaborator

NCT03213405Phase 1Completed

A Study to Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

Role: collaborator

NCT03158571Completed

Chilean Gastric Cancer Task Force (FORCE 1)

Role: collaborator

All 4 trials loaded